Ralph Zitnik

5.5k total citations · 4 hit papers
52 papers, 4.3k citations indexed

About

Ralph Zitnik is a scholar working on Immunology, Dermatology and Neurology. According to data from OpenAlex, Ralph Zitnik has authored 52 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Immunology, 12 papers in Dermatology and 11 papers in Neurology. Recurrent topics in Ralph Zitnik's work include Psoriasis: Treatment and Pathogenesis (19 papers), Vagus Nerve Stimulation Research (11 papers) and Dermatology and Skin Diseases (11 papers). Ralph Zitnik is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (19 papers), Vagus Nerve Stimulation Research (11 papers) and Dermatology and Skin Diseases (11 papers). Ralph Zitnik collaborates with scholars based in United States, Netherlands and United Kingdom. Ralph Zitnik's co-authors include Andrea Wang, Alice B. Gottlieb, Craig L. Leonardi, Kim Papp, Bernard S. Goffe, Robert Matheson, Stephen K. Tyring, Angelika Jahreis, Yaakov A. Levine and Michael Faltys and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Ralph Zitnik

49 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Etanercept as Monotherapy in Patients with Psoriasis

2003 935 citations Craig L. Leonardi, Bernard S. Goffe et al. profile →
Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial

2005 852 citations Stephen K. Tyring, Alice B. Gottlieb et al. The Lancet profile →
Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis

2016 706 citations Frieda A. Koopman, Simeon Grazio et al. profile →
A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction

2005 557 citations Kim Papp, Stephen K. Tyring et al. profile →

Peers

Countries citing papers authored by Ralph Zitnik

Since Specialization

Citations

This map shows the geographic impact of Ralph Zitnik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralph Zitnik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralph Zitnik more than expected).

Fields of papers citing papers by Ralph Zitnik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralph Zitnik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralph Zitnik. The network helps show where Ralph Zitnik may publish in the future.

Co-authorship network of co-authors of Ralph Zitnik

This figure shows the co-authorship network connecting the top 25 collaborators of Ralph Zitnik. A scholar is included among the top collaborators of Ralph Zitnik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralph Zitnik. Ralph Zitnik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Lebrikizumab in Uncontrolled Asthma: Reanalysis in a Well-Defined Type 2 Population 2024 ·The Journal of Allergy and Clinical Immunology In Practice ·Jonathan Corren, Stanley J. Szefler, Ellen Sher, Phillip E. Korenblat, Weily Soong, Nicola A. Hanania, Gary Berman, Guy Brusselle, Ralph Zitnik, Chitra R Natalie, Luna Sun, Kimberly Siu, Wen-Shuo Wu, Peter Lio, April W. Armstrong	18
2	Lebrikizumab Decreases Inflammatory Biomarkers in Patients with Asthma: Data from Randomized Phase 3 Trials (LAVOLTA I and II) 2023 ·Journal of Allergy and Clinical Immunology ·Stanley J. Szefler, Jonathan Corren, Jonathan I. Silverberg, Angela J. Okragly, Zhe Sun, Chitra R Natalie, Ralph Zitnik, Kimberly Siu, Andrew Blauvelt	2
3	Neuroimmune Modulation Through Vagus Nerve Stimulation Reduces Inflammatory Activity in Crohn’s Disease Patients: A Prospective Open-label Study 2023 ·Journal of Crohn s and Colitis ·Geert D’Haens, Michael Eberhardson, (unknown), Silvio Danese, (unknown), Mark Löwenberg, Gionata Fiorino, P. Richard Schuurman, Göran Lind, Per Almqvist, Peder S. Olofsson, Kevin J. Tracey, Stephen B. Hanauer, Ralph Zitnik, David Chernoff, Yaakov A. Levine	33
4	POS0119 XmAb564, A NOVEL POTENCY-REDUCED IL-2 FC FUSION PROTEIN SELECTIVELY EXPANDS REGULATORY T CELLS: RESULTS FROM A SINGLE ASCENDING DOSE STUDY IN HEALTHY ADULT VOLUNTEERS 2023 ·Raphael Clynes, (unknown), (unknown), (unknown), Jennifer Woo, (unknown), Jitendra Kanodia, Haixiang Sun, Ralph Zitnik	0
5	[VAGAL NERVE STIMULATION IN THE TREATMENT OF PATIENTS WITH RHEUMATOID ARTHRITIS – RESULTS THROUGH DAY 84 OBTAINED AT THE CROATIAN CENTER OF AN INTERNATIONAL PILOT STUDY]. 2018 ·PubMed ·(unknown), Simeon Grazio, Frane Grubišić, Ralph Zitnik	1
6	Single vagus nerve stimulation reduces early postprandial C-peptide levels but not other hormones or postprandial metabolism 2017 ·Clinical Rheumatology ·Man Tang, F. Samuel van Nierop, Frieda A. Koopman, Hannah M. Eggink, Daniëlle M. Gerlag, (unknown), Ralph Zitnik, Frédéric M. Vaz, Johannes A. Romijn, P. P. Tak, Maarten R. Soeters	6
7	Treatment of chronic inflammatory diseases with implantable medical devices 2011 ·Annals of the Rheumatic Diseases ·Ralph Zitnik	13
8	Treatment of chronic inflammatory diseases with implantable medical devices* 2011 ·Cleveland Clinic Journal of Medicine ·Ralph Zitnik	15
9	Modeling the Exposure‐Response Relationship of Etanercept in the Treatment of Patients With Chronic Moderate to Severe Plaque Psoriasis 2007 ·The Journal of Clinical Pharmacology ·Matthew M. Hutmacher, Ivan Nestorov, (unknown), Ralph Zitnik, Christopher Banfield	9
10	Pharmacokinetics of subcutaneously administered etanercept in subjects with psoriasis 2006 ·British Journal of Clinical Pharmacology ·Ivan Nestorov, Ralph Zitnik, Todd DeVries, Arline Nakanishi, Andrea Wang, Christopher Banfield	40
11	Etanercept monotherapy in patients with psoriasis: A summary of safety, based on an integrated multistudy database 2006 ·Journal of the American Academy of Dermatology ·Alice B. Gottlieb, Craig L. Leonardi, Bernard S. Goffe, Jean‐Paul Ortonne, P.C.M. KERKHOF, Ralph Zitnik, Arline Nakanishi, Angelika Jahreis	57
12	Patients with psoriasis respond to continuous open-label etanercept treatment after initial incomplete response in a randomized, placebo-controlled trial 2006 ·Journal of the American Academy of Dermatology ·Gerald G. Krueger, Boni E. Elewski, Kim Papp, Andrea Wang, Ralph Zitnik, Angelika Jahreis	39
13	No Evidence for Increased Risk of Cutaneous Squamous Cell Carcinoma in Patients With Rheumatoid Arthritis Receiving Etanercept for Up to 5 Years 2005 ·Archives of Dermatology ·Mark Lebwohl, Robin R. Blum, (unknown), Dennis Kim, Ralph Zitnik, (unknown), Wayne J. Wallis	43
14	Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial breakdown → 2005 ·The Lancet ·Stephen K. Tyring, Alice B. Gottlieb, Kim Papp, Ken Gordon, Craig L. Leonardi, Andrea Wang, Deepa Lalla, Michael Woolley, Angelika Jahreis, Ralph Zitnik, David Cella, Ranga Krishnan	852
15	Population Pharmacokinetic Modeling of Subcutaneously Administered Etanercept in Patients with Psoriasis 2004 ·Journal of Pharmacokinetics and Pharmacodynamics ·Ivan Nestorov, Ralph Zitnik, Thomas M. Ludden	17
16	Inhibition of Murine Neutrophil Serine Proteinases by Human and Murine Secretory Leukocyte Protease Inhibitor 1999 ·Biochemical and Biophysical Research Communications ·Clifford D. Wright, John A. Kennedy, Ralph Zitnik, Mohammed A. Kashem	30
17	The Cloning and Characterization of a Murine Secretory Leukocyte Protease Inhibitor cDNA 1997 ·Biochemical and Biophysical Research Communications ·Ralph Zitnik, Jue Zhang, Mohammed A. Kashem, Tadahiko Kohno, David E. Lyons, Clifford D. Wright, Eliot M. Rosen, Itzhak D. Goldberg, Adrian Hayday	48
18	Glucocorticoid Inhibition of Interleukin-1-Induced Interleukin-6 Production by Human Lung Fibroblasts: Evidence for Transcriptional and Post-Transcriptional Regulatory Mechanisms 1994 ·American Journal of Respiratory Cell and Molecular Biology ·Ralph Zitnik, (unknown), Jack A. Elias	50
19	IL-1 and transforming growth factor-beta regulation of fibroblast-derived IL-11. 1994 ·The Journal of Immunology ·Jack A. Elias, T. Zheng, (unknown), Terence K. Trow, William W. Merrill, Ralph Zitnik, Prabir Ray, (unknown)	91
20	Effects of In Vitro Amiodarone Exposureon Alveolar Macrophage Inflammatory Mediator Production 1992 ·The American Journal of the Medical Sciences ·Ralph Zitnik, John A. Cooper, John A. Rankin, (unknown)	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact